Authors
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
The Role of Pharmacists in Skin Care Education in the Age of Social MediaSocial media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.
Latest:
Clinical Considerations for Monkeypox in PregnancyWhat we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Latest:
Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HSResearchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
Latest:
Key Takeaways for Prurigo Nodularis TreatmentTJ Chao, MPAS, PA-C, discusses tips for educating patients and raising awareness about prurigo nodularis, focusing on the importance of informing patients about the role of systemic treatments and empowering them to make informed decisions about their care.
Latest:
FDA approves topical for actinic keratosisTirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
Latest:
Psychodermatology: An Opportunity for Collaboration Among Health Care ProfessionalsIn this CME article, learn more about the interdisciplinary field of psychodermatology and the collaborative health care team necessary for care.
Latest:
5 steps to make telehealth work for physicians and patientsThere are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.
Latest:
Psoriasis Associated with Increased Risk for Retinal DiseasesMore research is needed to understand the pathogenesis underlying this association.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
Seasonal Efficacy and Tolerability of Tazarotene in Warmer vs Colder MonthsResearchers have explored whether the adverse effects of tazarotene are exacerbated during the colder winter months and whether there is variation in treatment efficacy and tolerability between cold vs warm seasons.
Latest:
Recapping the Evolving Treatment Landscape for Atopic DermatitisThe panelist discusses how the therapeutic options for atopic dermatitis have expanded significantly with the emergence of targeted biologics, oral agents, and refined topical treatments, transforming the management approach for patients across the disease spectrum.
Latest:
Q&A with Becky Kamowitz of the Skin Cancer Foundation: Expanding Partnerships and Advancing Awareness in 2025As newly appointed Executive Director of the Foundation, Becky Kamowitz is combining public education with clinical needs in the fight against skin cancer.
Latest:
Facing Challenges in Pediatric Plaque PsoriasisIn a recent Dermatology Times DermView video series, “Advancing Care in Pediatric Plaque Psoriasis: Emerging Treatments and Management Strategies," Karan Lal, DO, and Helen Shin, MD, discuss pediatric psoriasis and its prevalence.
Latest:
Antimicrobial Resistance: Challenges and Potential SolutionsStephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Early Intervention for Port-Wine StainsAt the AAD Annual Meeting, Roy G. Geronemus, MD, emphasized the importance of early interventions for port wine stains.
Latest:
A Health Care Price Transparency Revolution is at HandPayers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.
Latest:
Advancing Sexual Health Histories in Dermatology: A Modernized Comprehensive Approach for Diverse PopulationsIn recent years, there has been a noticeable rise in diagnoses of sexually transmitted infections, often which present with skin findings.
Latest:
ICYMI: US FDA Recently Approves Stelara Biosimilar Ustekinumab-aekn for Psoriasis, Psoriatic ArthritisLast week, the US Food and Drug Administration approved biosimilar ustekinumab-aekn (Selarsdi; Alvotech and Teva) for psoriasis and PsA.
Latest:
Getting Started With Practice Tech: Pearls From Brandon Beal, MDBrandon Beal, MD shared his experience, which technology solutions work best, and resources available to dermatology practices.
Latest:
Tailored Strategies and Evolving Therapies for Plaque PsoriasisSong stressed the need for careful therapy selection in patients with comorbid conditions to avoid exacerbating health issues.
Latest:
A New Role for Will Kirby, DO, FAOCDHow does a dermatologist go from the clinic to the television screen? Editorial Board member Will Kirby, DO, FAOCD, shares his thoughts about reality television and his appearance The Traitors.
Latest:
Study Finds Disparities in Access to Patient Portals Despite a Rise in UseThe study found that white patients were offered access to patient portals more frequently than Black or Hispanic patients.
Latest:
Improve Patient Outcomes With Better Language AccessMedical practices can choose from a wide array of tools to enable communication with patients from diverse backgrounds.
